Nuveen Asset Management, LLC Citius Pharmaceuticals, Inc. Transaction History

Nuveen Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$1.08 - $1.65 $523,420 - $799,670	484,649 New	484,649 $581,000
Q2 2022 Aug 15, 2022	SELL	$0.88 - $1.87 $392,753 - $834,601	-446,311 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.38 - $1.89 $5,555 - $7,609	4,026 Added 0.91%	446,311 $795,000
Q4 2021 Feb 14, 2022	SELL	$1.51 - $2.2 $57,348 - $83,553	-37,979 Reduced 7.91%	442,285 $701,000
Q3 2021 Nov 12, 2021	SELL	$1.74 - $2.6 $6,862 - $10,254	-3,944 Reduced 0.81%	480,264 $999,000
Q2 2021 Aug 16, 2021	BUY	$1.51 - $4.23 $731,154 - $2.05 Million	484,208 New	484,208 $1.69 Million

23.7M

83.1K

32.1K

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $376M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.